SCHEMBL1122735

SCHEMBL1122735

Cn1cc(CC(NC(=O)c2ccc(OCCN(Cc3ccccc3)Cc3ccccc3)cc2)C(=O)O)c2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 8/20 0.51
PTPN1 P18031 2/20 0.50
ITGB3 P05106 2/20 0.44
ITGA2B P08514 1/20 0.44
GPR132 Q9UNW8 1/20 0.43
HTR5A P47898 1/20 0.42
GAA P10253 1/20 0.42
RAB9A P51151 1/20 0.42
PPARG P37231 1/20 0.41
ITGB1 P05556 2/20 0.41
ITGAV P06756 1/20 0.41
ITGA5 P08648 1/20 0.41
ITGA4 P13612 1/20 0.41
KMT2A Q03164 1/20 0.41
MMP2 P08253 1/20 0.40
MMP13 P45452 1/20 0.40
MMP14 P50281 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1123500 0.93 GAA (0.52) ADAM17PTPN1HTR5AGAARAB9A
SCHEMBL1122913 0.81 PTPN1 (0.56) PTPN1ITGB3ITGA2BGPR132GAA
SCHEMBL1122929 0.81 PPARG (0.59) PTPN1PPARGKMT2A
SCHEMBL1123050 0.80 PTPN1 (0.69) PTPN1ITGB3ITGA2BGPR132GAA
SCHEMBL1122721 0.79 PTPN1 (0.68) PTPN1ITGB3ITGA2BGPR132GAA
SCHEMBL1123517 0.78 PTPN1 (0.64) PTPN1ITGB3ITGA2BGPR132GAA
SCHEMBL1123437 0.78 PTPN1 (0.67) PTPN1ITGB3ITGA2BGPR132GAA
SCHEMBL1123282 0.77 PTPN1 (0.58) PTPN1ITGB3ITGA2BGPR132GAA
SCHEMBL1123375 0.75 PPARG (0.65) ADAM17PTPN1GPR132PPARGKMT2A
SCHEMBL1123056 0.75 PPARG (0.54) ADAM17PTPN1PPARGKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP disclosed
CN-1835914-A New benzamides as PPAR[upsilon] modulators S A L V A T LAB SA (ES) 2006-09-20 CN disclosed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed
EP-1644321-A2 NEW BENZAMIDES AS PPATY MODULATORS LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2006-04-12 EP disclosed
WO-2004110983-A2 NEW BENZAMIDES AS PPARϒ MODULATORS LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG ADAM17 4502/4885PTPN1 2708/4885ITGB3 1819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.